A Phase III control study of the safety and immunogenicity of vYF in pediatric population

Trial Identifier: VYF04
Sponsor: Sanofi
Start Date: July 2025
Primary Completion Date: August 2026
Study Completion Date: March 2030
Condition: Yellow Fever Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
HONDURAS San Pedro Sula, HONDURAS, 21104
HONDURAS Tegucigalpa, HONDURAS, 11101
MEXICO, Chihuahua Chihuahua, MEXICO, 31000
MEXICO, Coahuila de Zaragoza Torreón, Coahuila de Zaragoza, MEXICO, 27000
MEXICO, México Ecatepec De Morelos, México, MEXICO, 55075
MEXICO, Morelos Cuernavaca, Morelos, MEXICO, 62290
MEXICO, Yucatán Tizimín, Yucatán, MEXICO, 97700